Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis

B Zhang, JS Tzartos, M Belimezi, S Ragheb… - Archives of …, 2012 - jamanetwork.com
Objectives To determine whether patients with myasthenia gravis (MG) have serum
antibodies to lipoprotein-related protein 4 (LRP4), a newly identified receptor for agrin that is …

[引用][C] Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis

JS Tzartos - Archives of Neurology, 2012 - cir.nii.ac.jp
Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative
Myasthenia Gravis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細 …

[PDF][PDF] Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis

B Zhang, JS Tzartos, M Belimezi, S Ragheb… - ARCH …, 2012 - scholar.archive.org
Objectives: To determine whether patients with myasthenia gravis (MG) have serum
antibodies to lipoprotein-related protein 4 (LRP4), a newly identified receptor for agrin that is …

[引用][C] Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis

BIN ZHANG, JS TZARTOS, M BELIMEZI… - Archives of …, 2012 - pascal-francis.inist.fr
Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative
Myasthenia Gravis CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis

B Zhang, JS Tzartos, M Belimezi… - Archives of …, 2012 - pubmed.ncbi.nlm.nih.gov
Objectives To determine whether patients with myasthenia gravis (MG) have serum
antibodies to lipoprotein-related protein 4 (LRP4), a newly identified receptor for agrin that is …

Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.

B Zhang, JS Tzartos, M Belimezi, S Ragheb… - Archives of …, 2011 - europepmc.org
Objectives To determine whether patients with myasthenia gravis (MG) have serum
antibodies to lipoprotein-related protein 4 (LRP4), a newly identified receptor for agrin that is …

[PDF][PDF] Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis

B Zhang, JS Tzartos, M Belimezi, S Ragheb… - ARCH …, 2012 - academia.edu
Objectives: To determine whether patients with myasthenia gravis (MG) have serum
antibodies to lipoprotein-related protein 4 (LRP4), a newly identified receptor for agrin that is …

Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis

B Zhang, JS Tzartos, M Belimezi… - Archives of …, 2012 - augusta.elsevierpure.com
Objectives: To determine whether patients with myasthenia gravis (MG) have serum
antibodies to lipopro-tein-related protein 4 (LRP4), a newly identified receptor for agrin that …

[PDF][PDF] Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis

B Zhang, JS Tzartos, M Belimezi, S Ragheb… - ARCH …, 2012 - scholar.archive.org
Objectives: To determine whether patients with myasthenia gravis (MG) have serum
antibodies to lipoprotein-related protein 4 (LRP4), a newly identified receptor for agrin that is …

[PDF][PDF] Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis

B Zhang, JS Tzartos, M Belimezi, S Ragheb… - ARCH …, 2012 - academia.edu
Objectives: To determine whether patients with myasthenia gravis (MG) have serum
antibodies to lipoprotein-related protein 4 (LRP4), a newly identified receptor for agrin that is …